Zdrowie i gospodarka · 21/03/2018

FDA Extends Comment Period for Homeopathic Drug Guidance

The Food and Drug Administration (FDA) is extending the comment period for its draft guidance on drug products labeled as homeopathic, allowing industry stakeholders and the public more time to submit comments.